MIAMI, March 21, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTCPink:TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics, announced today plans to enter the $13 billion medicinal mushroom market with HAVN Life Sciences' biopharmaceuticals and Ei.Ventures MANA products. In advance of its acquisition of Ei.Ventures and plans to form PSLY.COM, Mycotopia Therapies has expanded its supply agreement with HAVN Life Sciences to include functional mushrooms, HAVN Life’s recently launched natural health products, and its line of white label products. PSLY.COM will also be the name of the recently acquired 12x 12 estate in The Sandbox, a virtual world where players can build, own, and monetize their gaming experiences on the Ethereum blockchain. This purchase, valued at $2.2 million, represents the third largest land sale in the Metaverse, and was the subject of a January 5, 2022 article in Forbes by A.J. Herrington titled Startup Plans Psychedelic Trips In The Metaverse With Sandbox Virtual Land Deal.
Mycotopia Therapies Inc. To Enter $13 Billion Medicinal Mushroom Market With HAVN Life Sciences' Biopharmaceuticals And Ei.Ventures MANA Products
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Intel%20Corp_%20logo%20on%20mobile%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
/Alphabet%20(Google)%20Image%20by%20Markus%20Mainka%20via%20Shutterstock.jpg)
/An%20image%20of%20a%20Tesla%20humanoid%20robot%20in%20front%20of%20the%20company%20logo%20Around%20the%20World%20Photos%20via%20Shutterstock.jpg)
/Nvidia%20logo%20by%20Konstantin%20Savusia%20via%20Shutterstock.jpg)
